ALNYLAM PHARMACEUTICALS, INC. Weighted Avg Shares (Diluted) 2019-2025 | ALNY
What is weighted avg shares (diluted)?
Weighted average shares outstanding (diluted) includes the basic share count plus all potentially dilutive securities such as stock options, warrants, and convertible bonds. It is used as the denominator to calculate diluted earnings per share.
What is ALNYLAM PHARMACEUTICALS, INC.'s current weighted avg shares (diluted)?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual weighted avg shares (diluted) for 2025 was 134.7M, a 5.51% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. weighted avg shares (diluted) for the quarter ending September 30, 2025 was 137.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s weighted avg shares (diluted) in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual weighted avg shares (diluted) for 2024 was 127.7M, a 2.20% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s weighted avg shares (diluted) in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual weighted avg shares (diluted) for 2023 was 124.9M, a 2.64% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year weighted avg shares (diluted) CAGR?
ALNYLAM PHARMACEUTICALS, INC. weighted avg shares (diluted) grew at a compound annual growth rate (CAGR) of 3.21% from FY2020 to FY2025, going from 115.0M to 134.7M over 5 years.
Year-over-year comparison from 10-K annual reports